Trial Profile
A study evaluating off target effect of Posaconazole delayed release tablets.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2017
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Chagas disease; Mycoses; Oropharyngeal candidiasis
- Focus Adverse reactions
- 23 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017